寻找Baclofinding的解决方案:巴克洛芬诱导的脑病变在腹腔透析患者
Ali AlShaqaq1, Muthana Al Sahlawi2, Abdulrazack Amir1
1Department of Medicine, Johns Hopkins Aramco Healthcare Center, Dhahran, Saudi Arabia.
概括
巴克洛芬毒性,对患有功能障碍的患者来说是一个风险,可以引起神经毒性. 这一案例突出显示了巴克洛芬诱导的脑病变在腹腔透析患者,成功地用连续透析治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴克洛芬是一种GABA激动剂,治疗肌肉性,但在功能障碍中由于排泄而造成神经毒性风险.
- 关于腹腔透析 (PD) 患者中巴克洛芬毒性的文献有限,这是一群处于药物积累风险的人群.
研究的目的:
- 在接受腹腔透析的患者中报告巴克洛芬诱导的脑病变.
- 突出这一特定患者群体中巴克洛芬毒性的管理和恢复.
主要方法:
- 一个关于腹透析患者经过单剂量后出现巴克洛芬诱导的脑病变的病例报告.
- 管理涉及持续 (24小时) 的自动PD,以加速巴克洛芬的消除.
主要成果:
- 患者在单次服用巴克洛芬后出现了巴克洛芬诱导的脑病变.
- 神经状态在持续自动化PD启动后的三天内完全恢复.
结论:
- 在PD患者中,即使使用单剂量也可能发生巴克洛芬毒性.
- 持续的PD有效地管理巴克洛芬诱导的脑病变,促进神经系统的快速恢复.
相关概念视频
Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
Drug Delivery: Parenteral Route
406
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
406
Skeletal Muscle Relaxants: Adverse Effects
334
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
334
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Depolarizing Blockers: Pharmocokinetics
305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305


